Page last updated: 2024-08-24

2'-deoxycytidine 5'-triphosphate and Granulocytic Leukemia

2'-deoxycytidine 5'-triphosphate has been researched along with Granulocytic Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buck, SA; Gurney, JG; Matherly, LH; Ravindranath, Y; Stout, ML; Taub, JW1
Leen, R; van Gennip, AH; van Kuilenburg, AB; Verschuur, AC; Voƻte, PA1
Plunkett, W; Xu, YZ1
Arentsen-Honders, MW; Colly, LP; Kester, MG; Richel, DJ; ter Riet, PM; Willemze, R1
Higashigawa, M; Kamiya, H; Kawasaki, H; Ohkubo, T; Sakurai, M1

Other Studies

5 other study(ies) available for 2'-deoxycytidine 5'-triphosphate and Granulocytic Leukemia

ArticleYear
Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.
    Blood, 1996, Apr-15, Volume: 87, Issue:8

    Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cell Line, Transformed; Cells, Cultured; Child; Child, Preschool; Chromosomes, Human, Pair 21; Cystathionine beta-Synthase; Cytarabine; Deoxycytosine Nucleotides; Disease-Free Survival; Down Syndrome; Female; Herpesvirus 4, Human; Homocysteine; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid; Male; Methotrexate; Myelodysplastic Syndromes; Neoplastic Stem Cells; Remission, Spontaneous; Survival Rate

1996
Cyclopentenyl cytosine increases the phosphorylation and incorporation into dna of arabinofu-ranosyl cytosine in a myeloid leukemic cell-line.
    Advances in experimental medicine and biology, 2000, Volume: 486

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carbon-Nitrogen Ligases; Cytarabine; Cytidine; Cytidine Diphosphate; Cytidine Monophosphate; Deoxycytosine Nucleotides; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Myeloid; Phosphorylation

2000
Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine.
    Biochemical pharmacology, 1992, Nov-03, Volume: 44, Issue:9

    Topics: Antimetabolites, Antineoplastic; Carbon Radioisotopes; Cell Extracts; Chromatography, High Pressure Liquid; Cytidine Deaminase; DCMP Deaminase; Deoxycytidine; Deoxycytosine Nucleotides; Gemcitabine; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Thymine Nucleotides; Tumor Cells, Cultured

1992
Increase in Ara-C sensitivity in Ara-C sensitive and -resistant leukemia by stimulation of the salvage and inhibition of the de novo pathway.
    Annals of hematology, 1992, Volume: 65, Issue:1

    Topics: Cell Division; Cytarabine; Deoxycytidine Kinase; Deoxycytosine Nucleotides; DNA; Drug Resistance; Humans; Hydroxyurea; Leukemia, Myeloid; Tumor Cells, Cultured

1992
Relationship between intracellular dCTP/ara-CTP ratio and cytotoxic effect of ara-C.
    Advances in experimental medicine and biology, 1989, Volume: 253B

    Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cytarabine; Deoxycytosine Nucleotides; Dose-Response Relationship, Drug; Humans; Leukemia, Myeloid; Leukemia, T-Cell; Mice; Spleen; Time Factors; Tumor Cells, Cultured

1989